Last viewed: endv


Prices are updated after-hours


nasdaq:ENDV ENDONOVO THERAPEUTICS, INC.

ENDV | $0.0028 158.07% 74K twitter stocktwits trandingview |
Professional, Scientific, and T...

(0.0% 1d) (6.7% 1m) (-78.9% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (124.3% volume)
Earnings Calendar:
Market Cap: $ 932,507

http://endonovo.com/
Sec Filling | Patents | n/a employees


(US) endonovo therapeutics (otcqb: endv) is an innovative biotechnology company developing a bioelectronic approach to regenerative medicine. endonovo's immunotronics™ platform is a non-invasive, non-implantable bioelectronic device for treating/preventing vital organ failure through the reduction of inflammation and necrosis, and the promotion of regeneration. endonovo's cytotronics™ platform provides for a method of expanding and manipulating cells using simulated microgravity and time-varying electromagnetic fields (tvemf) for tissue engineering and cell therapies.

t-cell  

add to watch list Paper trade email alert is off

Press-releases


Endonovo Closes Asset Purchase Agreement for a Minimum of $50M With SofPulse, Inc
Published: 2024-03-28 (Crawled : 13:00) - globenewswire.com
ENDV | $0.0028 158.07% 74K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 69.57% H: 48.72% C: -20.51%

agreement
Endonovo’s SofPulse® to Be Featured at Innovative Pain Management Solutions
Published: 2024-03-04 (Crawled : 14:00) - globenewswire.com
ENDV | $0.0028 158.07% 74K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 0.0% H: 12.12% C: 0.0%

sofpulse management solutions
Global Electroceuticals / Bioelectric Medicine Strategic Research Report 2023-2030: Overcoming Drawbacks of Traditional Treatments, Rising Incidence of Neurological Disorders and Need for Novel Therapies
Published: 2023-12-08 (Crawled : 23:00) - prnewswire.com
AXNX | $66.96 -0.13% -0.13% 590K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
STIM | $3.8 -0.78% -0.79% 49K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
ABT | News | $107.28 1.91% 0.18% 10M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
MDT | $79.48 0.37% -0.29% 6.7M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
ENDV | $0.0028 158.07% 74K twitter stocktwits trandingview |
Professional, Scientific, and T...
| Email alert Add to watchlist

report disorders research global neurological
Endonovo Signs Definitive Agreement to Sell SofPulse® Brand Business and IP to SofPulse Inc. for a minimum of $50 Million
Published: 2023-12-04 (Crawled : 14:00) - globenewswire.com
ENDV | $0.0028 158.07% 74K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 17.5% H: 13.48% C: -40.43%

sofpulse business agreement
Endonovo's SofPulse® Secures Taiwan FDA Approval
Published: 2023-10-12 (Crawled : 13:00) - globenewswire.com
ENDV | $0.0028 158.07% 74K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 22.0% H: 0.0% C: -11.48%

sofpulse fda approval
Endonovo’s SofPulse® Secures Federal Supply Schedule Inclusion to Accelerate Expansion of VA Distribution
Published: 2023-08-22 (Crawled : 13:20) - globenewswire.com
ENDV | $0.0028 158.07% 74K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 0.0% H: 0.0% C: -7.56%

sofpulse distribution expansion
Endonovo’s Breaking Barriers in With Patented Medical Technologies: 2023 Bi-Annual Update
Published: 2023-08-08 (Crawled : 13:00) - globenewswire.com
ENDV | $0.0028 158.07% 74K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: -2.63% H: 0.9% C: -5.41%

update medical
Endonovo Pending Agreement to Develop Telehealth Division
Published: 2023-06-07 (Crawled : 13:20) - globenewswire.com
ENDV | $0.0028 158.07% 74K twitter stocktwits trandingview |
Professional, Scientific, and T...
| Email alert Add to watchlist

agreement
Endonovo Launches SofPulse® into the Veterans Administration
Published: 2023-05-02 (Crawled : 13:20) - globenewswire.com
ENDV | $0.0028 158.07% 74K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 0.0% H: 11.67% C: -2.5%

sofpulse
Endonovo Reaches Out to Top Clinical Researchers to Collaborate on TBI Treatment Studies
Published: 2023-04-25 (Crawled : 13:20) - globenewswire.com
ENDV | $0.0028 158.07% 74K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: -3.13% H: 8.39% C: -18.06%

treatment
See all


Last 15 days Sec forms
File Id Form Published Date Transaction Date Direction Code Amount Transacted Owned Amount


Your Today's Watch List
Sign in to create a watchlist
Gainers vs Losers
67% 33%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance

EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services

NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services

INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |


Last 48 Hours Insiders Buying
RXO P 200000 | $19.37 2.32% 0.0% 1M twitter stocktwits trandingview |
n/a
| 23:00
RKT P 380 | $11.68 1.3% 0.17% 1.9M twitter stocktwits trandingview |
Finance
| 22:30
HROW P 29400 | $10.43 -3.87% -4.03% 680K twitter stocktwits trandingview |
Health Technology
| 22:30
BCDA P 2750 | $0.377 -1.4% 97K twitter stocktwits trandingview |
Health Technology
| 22:00
RMCF | $3.67 3.38% 3.27% 11K twitter stocktwits trandingview |
Consumer Non-Durables
| 20:10

12 months watchlist earnings calendar